Healthcare Enterprise Group rebuilds platform for innovative product R&D (research & development)
This article was originally published in Clinica
Executive Summary
When UK AIM-listed Healthcare Enterprise Group's medical technologies business model ran into trouble in late 2005, two board members stepped up to lead a recovery. Nine months and some radical decision-making later, the original business plan has been slotted back in place. HCEG non-executive chairman Mark Tompkins told Ashley Yeo what happened, why and what comes next